Back close

Dr. Anjali Murali

Assistant Professor, Department of Medical Oncology, School of Medicine, Kochi.

Qualification: DM, DNB, MBBS, MD

Bio

Dr. Anjali Murali currently serves as Assistant Professor at the Department of Medical Oncology, School of Medicine, Kochi. She completed her MBBS from Travancore Medical College, Kollam (University of Kerala) in 2014. She obtained her MD in Radiation Oncology from Government Medical College, Thiruvananthapuram (Kerala University of Health Sciences) in 2021 and DNB in Radiation Oncology from the National Board of Examinations, New Delhi, in 2021. She subsequently completed her DM in Medical Oncology from Amrita Institute of Medical Sciences and Research Centre, Kochi, in 2026.

 

Publications

Journal Article

Year : 2026

Gigantic hip mass as the initial presentation of hyperphosphatemic familial tumoral calcinosis: A case report

Cite this Research Publication : Surya Krishnan, Anjali Murali, Pavithran Keechilat, Gigantic hip mass as the initial presentation of hyperphosphatemic familial tumoral calcinosis: A case report, Archive of Oncology, National Library of Serbia, 2026, https://doi.org/10.2298/aoo250722014k

Publisher : National Library of Serbia

Year : 2025

The malayalam version of fear of cancer recurrence -7 scale: a cross sectional study on translation and validation among breast cancer survivors

Cite this Research Publication : Paul N, Sukumaran SV, Anjali M, Jose WM, Nikhil KH,
Pavithran K. The Malayalam version of fear of cancer recurrence -7 scale: a cross sectional study on translation and validation among breast cancer survivors. Cancer Research, Statistics and Treatment. 2025;8(4): 254‑62

Publisher : Wolters Kluwer

Year : 2024

Dengue Fever in Cancer Patients: A Case Series

Cite this Research Publication : Surya Krishnan, Alma Rose Devasia, Sivadas Swathi Krishna, Anjali Murali, Thareparambil Sathyapalan Dipu, Keechilat Pavithran, Dengue Fever in Cancer Patients: A Case Series, Amrita Journal of Medicine, Medknow, 2024, https://doi.org/10.4103/amjm.amjm_35_24

Publisher : Medknow

Year : 2024

Exceptional long term response to crizotinib in ROS 1‐postive advanced non small cell lung cancer

Cite this Research Publication : Anjali Murali, Anju Farsana A, Sobha Subramaniam, Malini Eapen, Indu R. Nair, Keechilat Pavithran, Exceptional long term response to crizotinib in ROS 1‐postive advanced non small cell lung cancer, Respirology Case Reports, Wiley, 2024, https://doi.org/10.1002/rcr2.70033

Publisher : Wiley

Qualification
  • MBBS
    Travancore Medical College, Kollam, University of Kerala (2009–2014)
  • MD,Radiation Oncology
    Government Medical College, Thiruvananthapuram, Kerala University of Health Sciences (2018–2021)
  • DNB, Radiation Oncology
    National Board of Examinations, New Delhi (2021)
  • DM, Medical Oncology
    Amrita Institute of Medical Sciences and Research Centre, Kochi (2023–2026)
Area of Expertise
  • Breast Cancer
  • Lung Cancer
  • Gastrointestinal Malignancies
  • Immunotherapy and Targeted Therapy
  • Supportive Oncology
  • Chemotherapy Administration and Toxicity Management
  • Precision Oncology
Experience
  • 2021 – 2022
    Senior Resident
    Department of Radiation Oncology, Government Medical College, Thiruvananthapuram Department of Radiation Oncology ,Government TD Medical College, Alappuzha
  • 2022 – 2023
    Assistant Professor
    Department of Radiation Oncology, Government TD Medical College, Alappuzha
  • 2026 – Present
    Assistant Professor
    Department of Medical Oncology, Amrita Institute of Medical Sciences and Research Centre, Kochi
Awards and Recognitions
  • Second Prize, Oral Presentation – CANVERSARY 2025, JIPMER Puducherry
  • Third Prize, Quiz – International Conference on Multidisciplinary Management of Common Cancers, 2024
Memberships
  • American Society of Clinical Oncology (ASCO)
  • European Society for Medical Oncology (ESMO)
  • Indian Society of Oncology (ISO)
  • Association of Radiation Oncologists of India (AROI)
  • Immuno-Oncology Society of India (IOSI)
  • Multinational Association of Supportive Care in Cancer (MASCC)
  • Society for Immunotherapy of Cancer (SITC)
  • American Society for Radiation Oncology (ASTRO)
Admissions Apply Now